<div class="pk-crumbs" data-crumbs="[{&quot;label&quot;:&quot;Drugs&quot;,&quot;href&quot;:&quot;README.md&quot;},{&quot;label&quot;:&quot;A07A&quot;,&quot;href&quot;:&quot;atc/A07A.md&quot;},{&quot;label&quot;:&quot;colistin&quot;}]"></div>
<div class="pk-recnav" data-items="[{&quot;id&quot;:&quot;Colistin_Ma2026_reference&quot;,&quot;label&quot;:&quot;Ma_2026_reference&quot;,&quot;href&quot;:&quot;drugs/drug_colistin/Colistin_Ma2026_reference.md&quot;,&quot;status&quot;:&quot;reviewed \u2014 candidate&quot;,&quot;css&quot;:&quot;pk-badge--green&quot;,&quot;here&quot;:false},{&quot;id&quot;:&quot;Colistin_Boonyasiri2025_reference&quot;,&quot;label&quot;:&quot;Boonyasiri_2025_reference&quot;,&quot;href&quot;:&quot;drugs/drug_colistin/Colistin_Boonyasiri2025_reference.md&quot;,&quot;status&quot;:&quot;needs review&quot;,&quot;css&quot;:&quot;pk-badge--orange&quot;,&quot;here&quot;:false},{&quot;id&quot;:&quot;Colistin_Yu2022_reference&quot;,&quot;label&quot;:&quot;Yu_2022_reference&quot;,&quot;href&quot;:&quot;drugs/drug_colistin/Colistin_Yu2022_reference.md&quot;,&quot;status&quot;:&quot;needs review&quot;,&quot;css&quot;:&quot;pk-badge--orange&quot;,&quot;here&quot;:false},{&quot;id&quot;:&quot;Colistin_Xie2022_reference&quot;,&quot;label&quot;:&quot;Xie_2022_reference&quot;,&quot;href&quot;:&quot;drugs/drug_colistin/Colistin_Xie2022_reference.md&quot;,&quot;status&quot;:&quot;rejected&quot;,&quot;css&quot;:&quot;pk-badge--red&quot;,&quot;here&quot;:false}]"></div>

# colistin

- **generic name:** colistin
- **ATC codes:** `A07AA10`, `J01XB01`
- **DrugBank:** [DB00803](https://go.drugbank.com/drugs/DB00803) · **PubChem:** [CID 131704173](https://pubchem.ncbi.nlm.nih.gov/compound/131704173)
- **groups:** approved, investigational

## About

**Description.** Cyclic polypeptide antibiotic from Bacillus colistinus. It is composed of Polymyxins E1 and E2 (or Colistins A, B, and C) which act as detergents on cell membranes. Colistin is less toxic than Polymyxin B, but otherwise similar; the methanesulfonate is used orally.

**Indication.** For the treatment of acute or chronic infections due to sensitive strains of certain gram-negative bacilli, particularly <i>Pseudomonas aeruginosa</i>.

## Extraction summary

| extracted at | time | popPK e/r/o | PD e/r/o (paper) | PGx e/r/o | tokens in/out | LLM | papers | GROBID/JATS | OA/non-OA | NONMEM |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-22 01:06 | 1:44 | 2/1/1 | 0/0/0 | 0/0/0 | 49,353/2,036 | ollama / qwen3.8:27b-mtp-q8_0 | 2 | 0/2 | 2/0 | 0 |

## popPK records

| status | detail | model | model structure | params | citation | doi |
|---|---|---|---|---|---|---|
| <span class="pk-badge pk-badge--green">reviewed — candidate</span> | [Ma_2026_reference](drugs/drug_colistin/Colistin_Ma2026_reference.md) | ▶ model + simulator | 1-compartment, IV | 2 | Ma Y et al., Optimizing Colistin Sulfate Dosing in S…, Drug design, development an… (2026) | [10.2147/DDDT.S600942](https://doi.org/10.2147/DDDT.S600942) |
| <span class="pk-badge pk-badge--orange">needs review</span><br><sub>blocking: T6_deviations</sub><br><sub>route_to: `engineer`</sub> | [Boonyasiri_2025_reference](drugs/drug_colistin/Colistin_Boonyasiri2025_reference.md) | ▶ model + simulator | 1-compartment, oral | 2 | Boonyasiri A et al., Disposition of colistin in critically-i…, Clinical microbiology and i… (2025) | [10.1016/j.cmi.2025.05.021](https://doi.org/10.1016/j.cmi.2025.05.021) |
| <span class="pk-badge pk-badge--orange">needs review</span><br><sub>blocking: C2_reference failed (ratio None)</sub><br><sub>route_to: `human_review`</sub> | [Yu_2022_reference](drugs/drug_colistin/Colistin_Yu2022_reference.md) | — | 1-compartment (no model) | 1 (+1 cov.) | Yu XB et al., Population Pharmacokinetics of Colistin…, Frontiers in pharmacology (2022) | [10.3389/fphar.2022.915958](https://doi.org/10.3389/fphar.2022.915958) |
| <span class="pk-badge pk-badge--red">rejected</span><br><sub>blocking: C8 unreachable/orphan compartment or unlinked metabolite</sub><br><sub>route_to: `human_review`</sub> | [Xie_2022_reference](drugs/drug_colistin/Colistin_Xie2022_reference.md) | — | 2-compartment (no model) | 3 | Xie YL et al., Population pharmacokinetics of intraven…, Frontiers in pharmacology (2022) | [10.3389/fphar.2022.967412](https://doi.org/10.3389/fphar.2022.967412) |

## ADME sites

Where this drug is handled, from DrugBank's curated enzymes / transporters / carriers and the KB's PGx genes, mapped to tissue through the ADME gene table. Compare it with other drugs on the [Sites & interactions](sites?drugs=colistin) page (add drugs there; the set becomes a link).

| process | tissue | actors (role) | evidence |
|---|---|---|---|
| absorption | small intestine | <sub>“…Very poor absorption from gastrointestinal tract.…”</sub> | prose |
| metabolism | bile duct | <sub>“…se can be recovered unchanged in the urine, and there is no biliary excretion, it can be a…”</sub> | prose |
| metabolism | kidney | <sub>“…As 80% of the dose can be recovered unchanged in the urine, and there is no biliary excret…”</sub> | prose |

<details class="legend">
<summary>Badge legend — what each badge means</summary>
<table><thead><tr><th>badge</th><th>what it means</th></tr></thead><tbody><tr><td><span class="pk-badge pk-badge--green">curated</span></td><td>hand-authored by a person — an exemplar, not an extraction.</td></tr><tr><td><span class="pk-badge pk-badge--green">extracted</span></td><td>the pipeline accepted the record: every closed-form check it could run passed.</td></tr><tr><td><span class="pk-badge pk-badge--green">reviewed — candidate</span></td><td>the reviewer ran the built model against the paper's own reported values and they agree — the best automatic verdict there is.</td></tr><tr><td><span class="pk-badge pk-badge--green">accepted (caveats)</span></td><td>the model replicates the paper, but an advisory check failed — the record page names the caveat under the badge and the drug page shows it under the status.</td></tr><tr><td><span class="pk-badge pk-badge--orange">needs review</span></td><td>extracted, then a check failed or a value looks implausible. The numbers are shown as read, not endorsed.</td></tr><tr><td><span class="pk-badge pk-badge--orange">built, not shipped</span></td><td>a model was built, but a core parameter fell back to a library default, so it is not shipped.</td></tr><tr><td><span class="pk-badge pk-badge--red">rejected</span></td><td>not accepted — the record is not a compartmental model, or nothing usable was extracted.</td></tr><tr><td><span class="pk-badge pk-badge--neutral">not modelled</span></td><td>pipeline state, not a judgement: no model has been built for this record yet (likewise `not simulated`).</td></tr><tr><td><span class="pk-badge pk-badge--stale">stale</span></td><td>the reviewer's verdict predates the latest re-run of the paper — treat the status as out of date, not as current.</td></tr><tr><td><span class="pk-badge pk-badge--green">cross-checked ✓</span></td><td>every independent reader agreed on every compared field. With more than one reader the badge counts them, e.g. 'cross-checked ✓ 2/2'.</td></tr><tr><td><span class="pk-badge pk-badge--orange">cross-check: partial</span></td><td>a reader differs on a non-structural field (a population label, a flag), or the readers do not all agree with each other.</td></tr><tr><td><span class="pk-badge pk-badge--red">cross-check: disputed</span></td><td>at least one reader differs on a structural parameter — a clearance, a volume, ka, a lag. The record still holds the FIRST reading; the disagreement is a signal for a reviewer, never an automatic correction.</td></tr></tbody></table>
<p><small>The first badge is the record's <b>status</b> — what the pipeline and the reviewer concluded. A second badge, when present, is the <b>cross-check</b>: whether a model of another family, re-reading the same paper, extracted the same numbers. They are independent — a rejected record can be cross-checked, and a confirmed reading can still fail a plausibility check.</small></p>
</details>

## Coverage

- **PubMed hits:** 142 matched, 20 returned
- **screened:** 4  ·  **relevant:** 4
- **records:** 4  ·  extracted 1  ·  needs_review 2  ·  rejected 1  ·  stale 0
- **scholar-agent fallback query used:** not captured

## Full text wanted

_4 paper(s) judged relevant from the abstract, with no full text on disk — paywalled, or the resolver could not reach them. Follow the DOI, then save the PDF into `papers/` as `&lt;save as&gt;.pdf` and re-run the extraction._

| save as | citation | domain | score | DOI | PubMed | why wanted |
|---|---|---|---|---|---|---|
| `Boonyasiri_2025.pdf` | Boonyasiri A et al., Disposition of colistin in critically-i…, Clinical microbiology and i… (2025) | popPK | 10 | [10.1016/j.cmi.2025.05.021](https://doi.org/10.1016/j.cmi.2025.05.021) | [40449589](https://pubmed.ncbi.nlm.nih.gov/40449589) | The paper is a population pharmacokinetic study of colistin and explicitly reports numeric values for clearance (1.69 L/h, 3.49 L/h) and volume of distribution (50.2 L) in the results section. |
| `Lee_2013.pdf` | Lee J et al., Population pharmacokinetic analysis of…, Antimicrobial agents and ch… (2013) | popPK | 10 | [10.1128/AAC.00271-13](https://doi.org/10.1128/AAC.00271-13) | [23439640](https://pubmed.ncbi.nlm.nih.gov/23439640) | The paper is a population PK study of colistin, but the specific numeric parameter values (CL, V, Q) are not listed in the provided text, only the half-life (6.6 h) is mentioned. |
| `Ma_2026.pdf` | Ma Y et al., Optimizing Colistin Sulfate Dosing in S…, Drug design, development an… (2026) | popPK | 10 | [10.2147/DDDT.S600942](https://doi.org/10.2147/DDDT.S600942) | [42325914](https://pubmed.ncbi.nlm.nih.gov/42325914) | The paper reports a population pharmacokinetic model for colistin sulfate with explicit numeric values for clearance (1.66 L/h) and volume of distribution (10.10 L) in the results section. |
| `Sun_2025.pdf` | Sun Q et al., Population pharmacokinetics of colistin…, Scientific reports (2025) | popPK | 10 | [10.1038/s41598-025-03503-9](https://doi.org/10.1038/s41598-025-03503-9) | [40419663](https://pubmed.ncbi.nlm.nih.gov/40419663) | The paper describes a population PK study for colistin sulfate, but the specific numeric parameter values (CL, V, Q, etc.) are not present in the provided evidence text. |

<sub>queue written 2026-09-22T01:05:44.330542+00:00</sub>

## Screened and excluded

| domain | paper | verdict | relevance | extractability | reason |
|---|---|---|---|---|---|
| popPK | Gontijo_2021 | irrelevant | 2 | 0 | The paper describes an optimal control method for dosage selection using a PK model but does not report specific quantitative population PK parameter values (CL, V, Q, ka) for colistin in the provided evidence. |
| popPK | Lee_2013 | relevant | 10 | 2 | The paper is a population PK study of colistin, but the specific numeric parameter values (CL, V, Q) are not listed in the provided text, only the half-life (6.6 h) is mentioned. |
| popPK | Sun_2025 | relevant | 10 | 0 | The paper describes a population PK study for colistin sulfate, but the specific numeric parameter values (CL, V, Q, etc.) are not present in the provided evidence text. |
| popPK | Zabidi_2021 | irrelevant | 2 | 0 | The paper is a systematic review that discusses discrepancies in PK parameters but does not provide original quantitative disposition values for colistin in the provided evidence. |
| popPK | Zamri_2025 | irrelevant | 2 | 3 | The paper is a systematic review summarizing ranges from other studies rather than reporting original quantitative PK parameters or a specific population model for colistin. |

---
<sub>Generated by `docs.py` (scholarv2) · newest extraction 2026-09-22 01:06 UTC</sub>
